A clinical laboratory scientist sees unusual darkly stained cytoplasmic inclusions in leukocytes that she has not seen before. She should:
a. Ignore them; they probably are not significant.
b. Report that the patient has Alder-Reilly anomaly.
c. Report toxic granulation if the patient is known to have an infection.
d. Have a supervisor or pathologist look at the cells.
ANS: D
Whenever a clinical laboratory scientist sees an unusual morphologic finding that he or she cannot identify, the slide should be referred to the supervisor or pathologist, following the laboratory's protocol for handling of such findings.
You might also like to view...
Respiratory home care contributes to achieving which of the following goals?
1. Improving patients' physical and social well-being 2. Ensuring cost-effective delivery of care 3. Supporting and maintaining patients' lives 4. Promoting patient and family self-sufficiency a. 2 and 4 only b. 1, 2, and 3 only c. 2 and 3 only d. 1, 2, 3, and 4
Which of the following devices is used to calibrate laboratory thermometers?
A. Barometer B. Gallium melting point cell C. Titanium freezing point cell D. Platinum cathode voltmeter
Any alternate method of specimen delivery should be validated for
A. agitation of the specimen. B. hemolysis. C. adverse effects on test results. D. all of these.
It is important to physically restrain a patient who is experiencing a seizure in order to prevent the patient from harming himself.
Answer the following statement true (T) or false (F)